Hudson Bay Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Hudson Bay Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$1.32M	–	1365
2026 Q1	$1.32M	Sell	50,000 -90,000	-64%	-$2.64M	﹤0.01%	839
2025 Q4	$4.06M	Hold	140,000	–	–	0.01%	558
2025 Q3	$3.89M	Sell	140,000 -15,000	-10%	-$379K	0.01%	616
2025 Q2	$3.77M	Hold	155,000	–	–	0.01%	627
2025 Q1	$3.22M	Hold	155,000	–	–	0.01%	709
2024 Q4	$3.65M	Buy	155,000 +5,000	+3%	+$123K	0.01%	556
2024 Q3	$3.84M	Buy	150,000 +80,000	+114%	+$2.04M	0.02%	471
2024 Q2	$1.64M	Buy	70,000 +5,000	+8%	+$126K	0.01%	545
2024 Q1	$1.87M	Hold	65,000	–	–	0.01%	462
2023 Q4	$2.13M	Buy	65,000 +30,000	+86%	+$816K	0.01%	440
2023 Q3	$975K	Hold	35,000	–	–	0.01%	567
2023 Q2	$1.19M	Sell	35,000 -5,000	-13%	-$157K	0.01%	569
2023 Q1	$1.2M	Hold	40,000	–	–	0.01%	572
2022 Q4	$1.13M	Buy	40,000 +25,000	+167%	+$793K	0.01%	673
2022 Q3	$493K	Sell	15,000 -45,000	-75%	-$1.65M	﹤0.01%	899
2022 Q2	$1.89M	Buy	+60,000	New	+$2.1M	0.01%	819
2021 Q3	–	Sell	-20,000	Closed	-$1.85M	–	990
2021 Q2	$1.85M	Buy	+20,000	New	+$1.7M	0.02%	642

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Hudson Bay Capital Management's ARKG Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 50,000 shares — an estimated $1.32M sold.

Hudson Bay Capital Management first reported a position in ARKG in Q2 2021 and held it in 17 quarters. The position peaked at $4.06M in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Hudson Bay Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 50,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.32M.
Hudson Bay Capital Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 17 quarters.
Hudson Bay Capital Management's ARK Genomic Revolution ETF position peaked at $4.06M in Q4 2025.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.